Literature DB >> 29916871

A Multicenter Matched Comparison of Transanal and Robotic Total Mesorectal Excision for Mid and Low-rectal Adenocarcinoma.

Lawrence Lee1,2, Borja de Lacy3, Marcos Gomez Ruiz4, Alexander Sender Liberman2, Matthew R Albert1, John R T Monson1, Antonio Lacy3, Seon Hahn Kim5, Sam B Atallah6.   

Abstract

OBJECTIVE: To compare the quality of surgical resection of transanal total mesorectal excision (TA-TME) and robotic total mesorectal excision (R-TME).
BACKGROUND: Both TA-TME and R-TME have been advocated to improve the quality of surgery for rectal cancer below 10 cm from the anal verge, but there are little data comparing TA-TME and R-TME.
METHODS: Data of patients undergoing TA-TME or R-TME for rectal cancer below 10 cm from the anal verge and a sphincter-saving procedure from 5 high-volume rectal cancer referral centers between 2011 and 2017 were obtained. Coarsened exact matching was used to create balanced cohorts of TA-TME and R-TME. The main outcome was the incidence of poor-quality surgical resection, defined as a composite measure including incomplete quality of TME, or positive circumferential resection margin (CRM) or distal resection margin (DRM).
RESULTS: Out of a total of 730 patients (277 TA-TME, 453 R-TME), matched groups of 226 TA-TME and 370 R-TME patients were created. These groups were well-balanced. The mean tumor height from the anal verge was 5.6 cm (SD 2.5), and 70% received preoperative radiotherapy. The incidence of poor-quality resection was similar in both groups (TA-TME 6.9% vs R-TME 6.8%; P = 0.954). There were no differences in TME specimen quality (complete or near-complete TA-TME 99.1% vs R-TME 99.2%; P = 0.923) and CRM (5.6% vs 6.0%; P = 0.839). DRM involvement may be higher after TA-TME (1.8% vs 0.3%; P = 0.051).
CONCLUSIONS: High-quality TME for patients with rectal adenocarcinoma of the mid and low rectum can be equally achieved by transanal or robotic approaches in skilled hands, but attention should be paid to the distal margin.

Entities:  

Mesh:

Year:  2019        PMID: 29916871     DOI: 10.1097/SLA.0000000000002862

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer.

Authors:  Evie Carchman; Daniel I Chu; Gregory D Kennedy; Melanie Morris; Marc Dakermandji; John R T Monson; Laura Melina Fernandez; Rodrigo Oliva Perez; Alessandro Fichera; Marco E Allaix; David Liska
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

Review 2.  Transanal total mesorectal excision for rectal cancer: hype or new hope?

Authors:  Chien-Chih Chen; Yi-Ling Lai; Andy Yi-Ming Cheng; Chun-Ho Chu; I-Ping Huang; Shung-Haur Yang
Journal:  J Gastrointest Oncol       Date:  2019-12

3.  Robotic vs. TaTME Rectal Surgery (ROTA STUDY) Matched Cohort Trial for Mid to Low Rectal Cancer Surgery Evaluation Trial in the Hands of an Experienced Surgeon.

Authors:  Ravish Jootun; Pedja Cuk; Mark Ellebæk; Per Vadgaard Andersen; Søren Salomon; Gunnar Baatrup; Issam Al-Najami; Jim Khan
Journal:  Int J Surg Protoc       Date:  2022-02-18

4.  Outcomes of robotic low anterior resection versus transanal total mesorectal excision for rectal cancer.

Authors:  J L B Buan; W Z So; X C Lim; C S Chong
Journal:  BJS Open       Date:  2021-09-06

5.  Impact of Surgical Approach on Surgical Resection Quality in Mid- and Low Rectal Cancer, A Bayesian Network Meta-Analysis.

Authors:  Xiaojie Wang; Zhifang Zheng; Qian Yu; Waleed M Ghareeb; Xingrong Lu; Ying Huang; Shenghui Huang; Shuangming Lin; Pan Chi
Journal:  Front Oncol       Date:  2021-08-11       Impact factor: 6.244

6.  UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer.

Authors:  Marco Milone; Michel Adamina; Alberto Arezzo; Nona Bejinariu; Luigi Boni; Nicole Bouvy; F Borja de Lacy; Raphaëla Dresen; Konstantinos Ferentinos; Nader K Francis; Joe Mahaffey; Marta Penna; George Theodoropoulos; Katerina Maria Kontouli; Dimitris Mavridis; Per Olav Vandvik; Stavros A Antoniou
Journal:  Surg Endosc       Date:  2022-02-25       Impact factor: 4.584

7.  Structured training curriculums for transanal total mesorectal excision in China: refinement is needed.

Authors:  Ximo Xu; Zhenghao Cai; Hong Zhang; Qing Xu; Mingyang Ren; Abe Fingerhut; Dachong Sha; Minhua Zheng; Jianwen Li; Yang Deng; Xiao Yang; Sen Zhang; Batuer Aikemu; Wei Qin; Duohuo Shu; Xinxiang Li; Jun You; Quan Wang; Bo Feng
Journal:  Ann Transl Med       Date:  2022-04

8.  Da Vinci Single-Port robot-assisted transanal mesorectal excision: a promising preclinical experience.

Authors:  Werner Kneist; Hubert Stein; Markus Rheinwald
Journal:  Surg Endosc       Date:  2020-05-11       Impact factor: 4.584

Review 9.  Role of minimally invasive surgery for rectal cancer.

Authors:  Kurt A Melstrom; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

Review 10.  Clinical Status and Future Prospects of Transanal Total Mesorectal Excision.

Authors:  Zichao Guo; Xiaopin Ji; Shaodong Wang; Yaqi Zhang; Kun Liu; Changgang Wang; Yang Deng; Tao Zhang; Xi Cheng; Ren Zhao
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.